Physician profile
Sheldon J Black
NPI 1922012699
$3,557.24
in general payments reported to CMS, 2019-2025
28 companies · $1,136 in 2025
The $1,136 reported for 2025 was more than what 82% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $527 · 2020: $36.40 · 2021: $110 · 2022: $585 · 2023: $540 · 2024: $623 · 2025: $1,136.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,245 · Education: $52.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,245.02 |
| Education | $52.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $815.83 | 2021-2025 | |
| Glaxosmithkline, LLC. | $713.15 | 2021-2025 | Nucala |
| Regeneron Healthcare Solutions, INC. | $530.35 | 2019-2025 | Dupixent |
| Optinose US, INC. | $284.69 | 2019-2023 | |
| Inspire Medical Systems, INC. | $208.94 | 2019-2025 | Inspire |
| Intersect Ent, INC. | $160.95 | 2019-2020 | |
| Medtronic USA, INC. | $141.71 | 2019 | |
| Horizon Therapeutics Plc | $105.18 | 2022 | |
| Sanofi-Aventis U.S. LLC | $76.41 | 2022-2025 | |
| Amgen INC. | $73.03 | 2025 | Tezspire |
| Integra Lifesciences Corporation | $63.41 | 2022-2024 | Instruments-Orthopedic, Integra Duo, Microfrance |
| Hikma Pharmaceuticals USA | $50.50 | 2022-2025 | Ryaltris |
| Medtronic, INC. | $36.91 | 2024 | Stealthstation S8 Platform, Propel |
| Stryker Corporation | $35.47 | 2019-2025 | Scopis Ent |
| Novartis Pharmaceuticals Corporation | $33.33 | 2019 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $30.52 | 2024 | Halo, Tula |
| Alk-Abello, INC | $22.32 | 2022 | |
| Abbvie INC. | $21.90 | 2023 | Ubrelvy, Qulipta |
| Merck Sharp & Dohme LLC | $20.96 | 2023 | |
| Hologic Sales and Service, LLC | $19.22 | 2022 | |
| Aerin Medical INC. | $18.33 | 2025 | |
| Paratek Pharmaceuticals, INC. | $18.25 | 2025 | Xhance |
| Acclarent, INC | $16.63 | 2019 | |
| Boston Scientific Corporation | $15.54 | 2019 | |
| Olympus America INC. | $13.46 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $11.64 | 2022 | |
| Arbor Pharmaceuticals, INC. | $11.52 | 2019 | |
| Ambu INC. | $7.09 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sheldon Black listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.